BridgeMD
New treatment option for Remimazolam
Official title Application of Remimazolam, Dexmedetomidine, and Esketamine in Pediatric Preoperative Sedation
ClinicalTrials.gov ID: NCT07050212
What this study is testing
What is remimazolam group?
remimazolam group is an investigational medicine, given as an infusion into a vein, being studied as a potential treatment for remimazolam.
Also referred to as remimazolam.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- By comparing the application effects of three drugs in pediatric preoperative sedation, this study explores the optimal medication regimen, aiming to provide safer, more effective, and more personalized medication options for pediatric preoperative sedation. Additionally, this research will also focus on the impact of these three drugs on postoperative agitation in children, offering valuable references for the overall management of pediatric surgical anesthesia.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 2 to 5. Healthy volunteers may be eligible.
You may be able to join if
- Children aged 2 to 5 years old
- the American Society of Anesthesiologists (ASA) physical status of Class I
- scheduled for adenotonsillectomy under general anesthesia, will be included.
You likely can't join if
- Abnormal lung function and respiratory system function
- airway obstruction or deformity, history of mental illness
- electrocardiogram indicating bradycardia
- history of cardiac disease
The study team makes the final eligibility decision.
Where it's taking place
- Wuhan, Hubei, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 2 years to 5 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Wuhan, Hubei, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.